With age, many changes affect the laryngeal structures; among them are the cricoarytenoid joints. These diarthrodial joints are formed by the articular facets of both the cricoid and arytenoid cartilages apposed in a multiaxial form.
Introduction
With age, many changes affect the laryngeal structures; among them are the cricoarytenoid joints. These diarthrodial joints are formed by the articular facets of both the cricoid and arytenoid cartilages apposed in a multiaxial form. 1 In the elderly-which for the purposes of this study we defined as those aged 65 years and older-the articulation begins eroding and the perichondrium becomes thicker, which affects the precise movement of the arytenoid cartilages over the cricoid cartilage and alters the position of the vocal folds during phonation. These histologic and structural changes result in a change in voice quality. [2] [3] [4] Among the different laryngeal imaging modalities, computed tomography (CT) is the best for assessing the cricoarytenoid joint. With its rapid image acquisition and low susceptibility to artifact induced by breathing and swallowing, it is considered by many to be the standard diagnostic imaging study for the evaluation of organic voice disorders. 5 Modern CT scanners allow for a reconstruction of high-quality images in multiple planes and orientations, and they provide excellent spatial resolution. 5 While numerous reports have been published on the acoustic changes and voice symptoms often experienced by patients with presbyphonia, we found only two studies in the English-language literature that have described CT changes in the cricoarytenoid joint brought about by aging. 6, 7 To the best of our knowledge, no other radiologic study has examined age-related changes affecting the cricoarytenoid joint using CT. In this article, we describe what we believe is only the third study of radiologic changes at the level of the cricoarytenoid joint as they relate to age.
Patients and methods
We retrospectively reviewed the charts of all patients who underwent CT of the neck at our medical center from July 2015 through March 2016. After excluding patients with rheumatologic disease, vocal fold paraly-INDICATIONS OTOVEL® (ciprofl oxacin and fl uocinolone acetonide) is indicated for the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients (aged 6 months and older) due to S. aureus, S. pneumoniae, H. infl uenzae, M. catarrhalis, and P. aeruginosa.
IMPORTANT SAFETY INFORMATION

Contraindications
OTOVEL is contraindicated in:
• Patients with known hypersensitivity to fl uocinolone acetonide or other corticosteroids, ciprofl oxacin or other quinolones, or to any other component of OTOVEL.
• Viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections.
The following Warnings and Precautions have been associated with OTOVEL: hypersensitivity reactions, potential for microbial overgrowth with prolonged use, and continued or recurrent otorrhea.
The most common adverse reactions are otorrhea, excessive granulation tissue, ear infection, ear pruritis, tympanic membrane disorder, auricular swelling, and balance disorder. For the treatment of AOMT in pediatric patients due to S. aureus, S. pneumoniae, H. infl uenzae, M. catarrhalis, and P. aeruginosa. 
DOSAGE AND ADMINISTRATION
• OTOVEL is for otic use only. It is not for ophthalmic use, or for injection.
The recommended dosage regimen is as follows:
• Instill the contents of one single-dose vial 0.25 mL into the affected ear canal twice daily (approximately every 12 hours) for 7 days. Use this dosing for patients aged 6 months of age and older.
• Warm the solution by holding the vial in the hand for 1 to 2 minutes. This is to avoid dizziness, which may result from the instillation of a cold solution into the ear canal.
• The patient should lie with the affected ear upward, and then instill the medication.
• Pump the tragus 4 times by pushing inward to facilitate penetration of the medication into the middle ear.
• Maintain this position for 1 minute. Repeat, if necessary, for the opposite ear [see Instructions for Use]. 
DOSAGE FORMS AND STRENGTHS
CONTRAINDICATIONS
OTOVEL is contraindicated in:
• Patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of OTOVEL.
WARNINGS AND PRECAUTIONS
Hypersensitivity Reactions
OTOVEL should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolones. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dyspnea, urticaria and itching. Serious acute hypersensitivity reactions may require immediate emergency treatment.
Potential for Microbial Overgrowth with Prolonged Use
Prolonged use of OTOVEL may result in overgrowth of non-susceptible bacteria and fungi. If the infection is not improved after one week of treatment, cultures should be obtained to guide further treatment. If such infections occur, discontinue use and institute alternative therapy.
Continued or Recurrent Otorrhea
If otorrhea persists after a full course of therapy, or if two or more episodes of otorrhea occur within 6 months, further evaluation is recommended to exclude an underlying condition such as cholesteatoma, foreign body, or a tumor.
ADVERSE REACTIONS
The following serious adverse reactions are described elsewhere in the labeling: Hypersensitivity Reactions [see Warnings and Precautions (5.1)]
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In clinical trials, 224 patients with AOMT were treated with OTOVEL for a median duration of 7 days. All the patients received at least one dose of OTOVEL. There were 220 patients who received at least one dose of ciprofloxacin (CIPRO) and 213 patients received at least one dose of fluocinolone acetonide (FLUO). The most common adverse reactions that occurred in 1 or more patients are as follows: Selected adverse reactions that occurred in ≥ 1 patient in the OTOVEL group derived from all reported adverse events that could be related to the study drug or the drug class.
Postmarketing Experience
The following adverse reactions have been identified during postapproval use of ciprofloxacin and fluocinolone acetonide otic solution, 0.3% / 0.025% outside the US. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
• Immune system disorders: allergic reaction.
• Infections and infestations: candidiasis.
• Nervous system disorders: dysgeusia, paresthesia (tingling in ears), dizziness, headache.
• Ear and labyrinth disorders: ear discomfort, hypoacusis, tinnitus, ear congestion.
• Vascular disorders: flushing.
• Skin and subcutaneous tissue disorders: skin exfoliation.
• Injury, poisoning and procedural complications: device occlusion (tympanostomy tube obstruction).
USE IN SPECIFIC POPULATIONS 8.1 Pregnancy
Risk Summary OTOVEL is negligibly absorbed following otic administration and maternal use is not expected to result in fetal exposure to ciprofloxacin and fluocinolone acetonide (12.
3)].
Lactation
Risk Summary OTOVEL is negligibly absorbed by the mother following otic administration and breastfeeding is not expected to result in exposure of the infant to ciprofloxacin and fluocinolone acetonide.
Pediatric Use
OTOVEL has been studied in patients as young as 6 months in adequate and wellcontrolled clinical trials. No major differences in safety and effectiveness have been observed between adult and pediatric patients.
Geriatric Use
Clinical studies of OTOVEL did not include sufficient numbers of subjects aged 65 years and over to determine whether they respond differently from younger subjects.
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.
OVERDOSAGE
Due to the characteristics of this preparation, no toxic effects are to be expected with an otic overdose of OTOVEL. sis, laryngeal lesions, and a history of laryngeal cancer, laryngeal surgery, or irradiation, our study population was made up of 100 patients.
We analyzed this population on the basis of age, using 65 years as the cutoff threshold. A total of 49 patients (27 men and 22 women) were younger than 65 years and 51 (25 men and 26 women) were aged 65 or older. There were no significant differences between the two groups in the overall number of patients in each group or the number of men and women in each group.
Axial, coronal, and sagittal CT images of the neck were obtained on a 64-slice machine (SOMATOM Sensation 64; Siemens; Erlangen, Germany). The images were displayed at a window level of 150 Hounsfield units (HU) and a width of 650 HU to optimize the evaluation of the cartilage and surrounding soft tissues. The scans were reviewed by an experienced radiologist, who made anatomic measurements at the level of the cricoarytenoid joint to determine the presence and degree of ankylosis, narrowing, erosion, and density changes.
A normal-appearing cricoarytenoid joint was defined as one with a clearly visible soft-tissue plane between the articular surface of the cricoid cartilage and the surface of the arytenoid cartilage on two or more orthogonal planes, with homogeneous density of the cartilage (figure 1).
Ankylosis was defined as a complete fusion of the joint secondary to severe joint space narrowing, which was defined as the loss of the radiolucent intercartilaginous space between the cricoid and arytenoid cartilages (figure 2). Erosion was defined as the destruction of the articular cartilage at its surface (figure 3). Finally, density changes were defined as areas of increased density, particularly calcification at the articular surface of the cricoarytenoid joint (figure 4).
These four variables were classified as either present or absent. Because the cricoarytenoid joint is a multiaxial joint and cannot be completely visualized in a single slice, the presence of any variable needed to be identified on two or more planes.
Statistical analysis. Statistical analysis was performed with the Statistical Package for the Social Sciences software (v. 23). The association between age group and each variable was examined with the chi-square test and the Fisher exact test (for expected counts <5), and p values were reported.
Further analysis was conducted to examine associations according to which side of the neck was affected. Finally, age was also studied as a continuous measure. With the age distribution significantly deviating from normality (p <0.05; Shapiro-Wilk test), the nonparametric Mann-Whitney U test was used to examine the differences in median age between the two groups in terms of whether findings were present or absent. A p value of <0.05 was considered significant. Ethical considerations. Before the initiation of our analysis, the study protocol was approved by the Institutional Review Board of the American University at Beirut Medical Center.
Results
The prevalence of cricoarytenoid joint ankylosis was significantly higher in the older group (p = 0.036). Joint narrowing was more common in the older group, but the difference did not reach statistical significance (p = 0.112). Only a slightly greater prevalence of joint erosion and increased density was seen in the older group (table 1) .
With respect to the side of diagnosis (some patients exhibited bilateral involvement), the only significant difference on the right side was the presence of ankylosis, which was more prevalent in the older group (p = 0.026). On the left side, the older group had significantly more ankylosis (p = 0.026) and narrowing (p = 0.028) (table 2).
When age was taken as a continuous variable, the mean age of patients with ankylosis and narrowing was significantly higher than the age of those in whom these variables were absent (table 3) .
Discussion
The laryngeal cartilage is of the hyaline type, and its ossification process begins around the age of 20 years; it occurs secondary to the progressive replacement of the cartilaginous tissue by lamellar bone and hematopoietic tissue. 3 In elderly patients, the perichondrium of the cricoid and arytenoid cartilages becomes thicker, as the formation of cartilaginous fibrillations can be seen on light microscopy. 8 Furthermore, the cricoarytenoid joint exhibits erosion and roughening of its surfaces, which worsen progressively as the formation of chondrocyte clusters leads to exposure of the collagenous fibers. [8] [9] [10] These changes, along with a decrease in the adherent properties of the joint capsule, affect the precise movement of the arytenoid cartilage over the cricoid cartilage, which in turn ultimately affects vocal fold movement and quality of voice. 4, 11 CT is frequently used for laryngeal imaging. As previously mentioned, CT changes in the cricoarytenoid joint with age were previously looked at in two studies, but both carried some limitations. 6, 7 In 1982, Yeager et al published a cadaveric study of 30 adult larynges. 6 Specimens had been obtained from 16 men and 14 women, all of whom were 50 years of age or older. The authors looked at patterns of ossification in the cricoarytenoid joint on CT. Twenty-one of 32 cricoarytenoid joint specimens showed a complete ossification of the vocal process, and 23 of 31 specimens exhibited some ossification of the arytenoid body.
As for the cricoid cartilage, their study found a difference in ossification between the inner and outer surfaces in the male donors; complete ossification was present on the inner surface in 12 specimens and on the outer surface in only 7. 6 Less ossification was seen at the level of the cricoid arch. No correlation was found between patterns of ossification and age. In addition, the pattern of ossification was more prominent on the left side than on the right, which led the authors to conclude that patterns of ossification are mainly asymmetric. No other radiologic features of the cricoarytenoid joint were looked at in this study.
A few years later, Cérat et al reported their histologic and radiologic examination of 8 cadaveric larynges using 1.5-mm contiguous CT slices. 7 They described the radiologic appearances of the cricoarytenoid joints as being either radiolucent or radiopaque. In 2 cases, the cricoid and arytenoid cartilages lacked calcification and were not visible. In addition, the cricoarytenoid joint could not be assessed in 3 other cases because the cartilages had not mineralized enough. In the 3 remaining cases, the cricoarytenoid joint was either radiolucent or radiopaque whenever the cricoid and arytenoid cartilages were overlapping.
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Age-relAted chAnges Affecting the cricoArytenoid joint seen on computed tomogrAphy studies performed on the aging cricoarytenoid joint in which erosion and roughening of the joint surfaces were observed. 10, 12 Increased ankylosis and joint narrowing can also be attributable to changes affecting the synovial membrane, which constitutes the internal lining of the joint. The synovial membrane undergoes many histopathologic changes with age, including its replacement by chondrocyte clusters and a loss or decrease in its blood capillaries, macrophages, and lymphocytes. 8, 12 Our study found an asymmetry in changes affecting the cricoarytenoid joint with age. Specifically, narrowing in the aged joint was statistically significant only on the left side, which is consistent with the findings of Yeager et al, who reported an increased ossification of the cartilages and joint on the left. 6 Based on these findings, we concur that patterns of ossification affecting the cricoarytenoid joint are mainly asymmetric.
To the best of our knowledge, our study is the first to look at multiple radiologic parameters of the cricoarytenoid joint in association with aging. Nevertheless, it does have some limitations that might be addressed in future research projects. One is its The Cérat study was limited because only axial views were used to assess the cricoarytenoid joints, which hindered the possibility of evaluating the joint in a three-dimensional fashion. 7 Cartilage cortices are obliquely oriented and cannot be well evaluated on axial cuts. This is in addition to the limitations of their small sample size in that the radiologic evaluation of the joint was made on only 3 larynges.
Both of these studies failed to examine anatomic changes such as cricoarytenoid joint ankylosis, erosion, and soft-tissue changes. The results of our investigation indicate a significantly higher prevalence of ankylosis in our older group than in our younger group, as well as a trend toward joint narrowing in the older group. Our findings corroborate the results of histopathologic retrospective nature, which limited our ability to acquire information on our patients' phonatory behavior, voice quality, and endoscopic laryngeal findings. Another is the absence of indirect laryngeal examination, which would have been of value in excluding other possible laryngeal pathologies such as vocal fold paresis and in allowing us to draw other conclusions of possible clinical significance.
In conclusion, ankylosis and narrowing of the cricoarytenoid joint are commonly observed with aging. CT can be used to measure these changes and assist in the workup of elderly patients with dysphonia and abnormal vocal fold movement disorders.
